nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—MPO—chronic obstructive pulmonary disease	0.444	1	CbGaD
Dapsone—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.0538	0.145	CbGbCtD
Dapsone—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0466	0.126	CbGbCtD
Dapsone—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0344	0.0926	CbGbCtD
Dapsone—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0344	0.0926	CbGbCtD
Dapsone—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0311	0.0836	CbGbCtD
Dapsone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0286	0.077	CbGbCtD
Dapsone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0286	0.077	CbGbCtD
Dapsone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0219	0.0591	CbGbCtD
Dapsone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0217	0.0583	CbGbCtD
Dapsone—FMO3—sweat—chronic obstructive pulmonary disease	0.0213	0.534	CbGeAlD
Dapsone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0148	0.0399	CbGbCtD
Dapsone—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0144	0.0389	CbGbCtD
Dapsone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0141	0.0381	CbGbCtD
Dapsone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0126	0.0339	CbGbCtD
Dapsone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00739	0.0199	CbGbCtD
Dapsone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00698	0.0188	CbGbCtD
Dapsone—Pulmonary eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00576	0.0954	CcSEcCtD
Dapsone—Nerve injury—Prednisolone—chronic obstructive pulmonary disease	0.00267	0.0441	CcSEcCtD
Dapsone—PTGS2—leg—chronic obstructive pulmonary disease	0.0023	0.0578	CbGeAlD
Dapsone—Application site reaction—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.0358	CcSEcCtD
Dapsone—Nerve injury—Prednisone—chronic obstructive pulmonary disease	0.00194	0.0321	CcSEcCtD
Dapsone—FMO3—respiratory system—chronic obstructive pulmonary disease	0.00191	0.048	CbGeAlD
Dapsone—Albuminuria—Aminophylline—chronic obstructive pulmonary disease	0.00189	0.0313	CcSEcCtD
Dapsone—Suicide attempt—Montelukast—chronic obstructive pulmonary disease	0.00185	0.0307	CcSEcCtD
Dapsone—CYP2C18—bronchus—chronic obstructive pulmonary disease	0.00164	0.0411	CbGeAlD
Dapsone—FMO3—bronchus—chronic obstructive pulmonary disease	0.00157	0.0395	CbGeAlD
Dapsone—Skin exfoliation—Aminophylline—chronic obstructive pulmonary disease	0.00135	0.0223	CcSEcCtD
Dapsone—Influenza—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.022	CcSEcCtD
Dapsone—MPO—respiratory system—chronic obstructive pulmonary disease	0.00126	0.0316	CbGeAlD
Dapsone—Sinusitis—Roflumilast—chronic obstructive pulmonary disease	0.00111	0.0184	CcSEcCtD
Dapsone—MPO—connective tissue—chronic obstructive pulmonary disease	0.00111	0.0279	CbGeAlD
Dapsone—FMO3—lung—chronic obstructive pulmonary disease	0.00102	0.0255	CbGeAlD
Dapsone—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.000832	0.0138	CcSEcCtD
Dapsone—Sinusitis—Tiotropium—chronic obstructive pulmonary disease	0.000699	0.0116	CcSEcCtD
Dapsone—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000698	0.0115	CcSEcCtD
Dapsone—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000698	0.0115	CcSEcCtD
Dapsone—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000683	0.0113	CcSEcCtD
Dapsone—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.000683	0.0113	CcSEcCtD
Dapsone—Influenza—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.0112	CcSEcCtD
Dapsone—Influenza—Formoterol—chronic obstructive pulmonary disease	0.000674	0.0112	CcSEcCtD
Dapsone—MPO—lung—chronic obstructive pulmonary disease	0.000669	0.0168	CbGeAlD
Dapsone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000666	0.0167	CbGeAlD
Dapsone—Pharyngitis—Tiotropium—chronic obstructive pulmonary disease	0.000664	0.011	CcSEcCtD
Dapsone—Influenza—Montelukast—chronic obstructive pulmonary disease	0.00066	0.0109	CcSEcCtD
Dapsone—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000659	0.0109	CcSEcCtD
Dapsone—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.000647	0.0107	CcSEcCtD
Dapsone—Influenza—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.0105	CcSEcCtD
Dapsone—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000621	0.0156	CbGeAlD
Dapsone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000618	0.0102	CcSEcCtD
Dapsone—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000598	0.015	CbGeAlD
Dapsone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.000597	0.00989	CcSEcCtD
Dapsone—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.000577	0.00956	CcSEcCtD
Dapsone—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000572	0.0144	CbGeAlD
Dapsone—Sinusitis—Arformoterol—chronic obstructive pulmonary disease	0.000564	0.00934	CcSEcCtD
Dapsone—Sinusitis—Formoterol—chronic obstructive pulmonary disease	0.000564	0.00934	CcSEcCtD
Dapsone—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.000556	0.00921	CcSEcCtD
Dapsone—Sinusitis—Montelukast—chronic obstructive pulmonary disease	0.000552	0.00915	CcSEcCtD
Dapsone—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000549	0.00908	CcSEcCtD
Dapsone—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000536	0.00887	CcSEcCtD
Dapsone—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000536	0.00887	CcSEcCtD
Dapsone—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000533	0.00882	CcSEcCtD
Dapsone—PTGS1—connective tissue—chronic obstructive pulmonary disease	0.000526	0.0132	CbGeAlD
Dapsone—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000525	0.00869	CcSEcCtD
Dapsone—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000508	0.00841	CcSEcCtD
Dapsone—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00837	CcSEcCtD
Dapsone—PTGS2—connective tissue—chronic obstructive pulmonary disease	0.000503	0.0126	CbGeAlD
Dapsone—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000492	0.00814	CcSEcCtD
Dapsone—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000482	0.0121	CbGeAlD
Dapsone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00048	0.00795	CcSEcCtD
Dapsone—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00787	CcSEcCtD
Dapsone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000473	0.00783	CcSEcCtD
Dapsone—PTGS2—bronchus—chronic obstructive pulmonary disease	0.00047	0.0118	CbGeAlD
Dapsone—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000464	0.00768	CcSEcCtD
Dapsone—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00046	0.0116	CbGeAlD
Dapsone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000456	0.00754	CcSEcCtD
Dapsone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000449	0.00743	CcSEcCtD
Dapsone—PTGS1—trachea—chronic obstructive pulmonary disease	0.000442	0.0111	CbGeAlD
Dapsone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00043	0.00711	CcSEcCtD
Dapsone—Sulfamethazine—ALB—chronic obstructive pulmonary disease	0.000424	0.316	CrCbGaD
Dapsone—PTGS2—trachea—chronic obstructive pulmonary disease	0.000422	0.0106	CbGeAlD
Dapsone—Sulfamerazine—ALB—chronic obstructive pulmonary disease	0.000414	0.309	CrCbGaD
Dapsone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00682	CcSEcCtD
Dapsone—Cough—Formoterol—chronic obstructive pulmonary disease	0.00041	0.00679	CcSEcCtD
Dapsone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00041	0.00679	CcSEcCtD
Dapsone—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00668	CcSEcCtD
Dapsone—Cough—Montelukast—chronic obstructive pulmonary disease	0.000402	0.00665	CcSEcCtD
Dapsone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.0066	CcSEcCtD
Dapsone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.00659	CcSEcCtD
Dapsone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000398	0.00659	CcSEcCtD
Dapsone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00643	CcSEcCtD
Dapsone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000387	0.00641	CcSEcCtD
Dapsone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000376	0.00622	CcSEcCtD
Dapsone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000374	0.00619	CcSEcCtD
Dapsone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000374	0.00619	CcSEcCtD
Dapsone—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.00617	CcSEcCtD
Dapsone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000358	0.00593	CcSEcCtD
Dapsone—CYP3A5—lung—chronic obstructive pulmonary disease	0.000353	0.00887	CbGeAlD
Dapsone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000353	0.00585	CcSEcCtD
Dapsone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000347	0.00574	CcSEcCtD
Dapsone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000347	0.00574	CcSEcCtD
Dapsone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00034	0.00562	CcSEcCtD
Dapsone—CYP2E1—lung—chronic obstructive pulmonary disease	0.00033	0.00828	CbGeAlD
Dapsone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000327	0.00542	CcSEcCtD
Dapsone—Sulfamethizole—ALB—chronic obstructive pulmonary disease	0.000321	0.24	CrCbGaD
Dapsone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00032	0.0053	CcSEcCtD
Dapsone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000319	0.00528	CcSEcCtD
Dapsone—PTGS1—lung—chronic obstructive pulmonary disease	0.000318	0.00797	CbGeAlD
Dapsone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000316	0.00522	CcSEcCtD
Dapsone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00519	CcSEcCtD
Dapsone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00519	CcSEcCtD
Dapsone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00508	CcSEcCtD
Dapsone—PTGS2—lung—chronic obstructive pulmonary disease	0.000304	0.00762	CbGeAlD
Dapsone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00502	CcSEcCtD
Dapsone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00502	CcSEcCtD
Dapsone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000303	0.00502	CcSEcCtD
Dapsone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000303	0.00502	CcSEcCtD
Dapsone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000302	0.005	CcSEcCtD
Dapsone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00496	CcSEcCtD
Dapsone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000299	0.00495	CcSEcCtD
Dapsone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000298	0.00493	CcSEcCtD
Dapsone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00491	CcSEcCtD
Dapsone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000297	0.00491	CcSEcCtD
Dapsone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.0049	CcSEcCtD
Dapsone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00474	CcSEcCtD
Dapsone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00474	CcSEcCtD
Dapsone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000282	0.00467	CcSEcCtD
Dapsone—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000271	0.00448	CcSEcCtD
Dapsone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00026	0.00431	CcSEcCtD
Dapsone—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000254	0.00421	CcSEcCtD
Dapsone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00404	CcSEcCtD
Dapsone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00404	CcSEcCtD
Dapsone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00024	0.00398	CcSEcCtD
Dapsone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00024	0.00398	CcSEcCtD
Dapsone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00024	0.00397	CcSEcCtD
Dapsone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000239	0.00395	CcSEcCtD
Dapsone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000235	0.00389	CcSEcCtD
Dapsone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000232	0.00384	CcSEcCtD
Dapsone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00381	CcSEcCtD
Dapsone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.00378	CcSEcCtD
Dapsone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00377	CcSEcCtD
Dapsone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00377	CcSEcCtD
Dapsone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000227	0.00375	CcSEcCtD
Dapsone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00369	CcSEcCtD
Dapsone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00356	CcSEcCtD
Dapsone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000203	0.00335	CcSEcCtD
Dapsone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000188	0.00311	CcSEcCtD
Dapsone—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00306	CcSEcCtD
Dapsone—Sulfamethoxazole—ALB—chronic obstructive pulmonary disease	0.00018	0.135	CrCbGaD
Dapsone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000174	0.00288	CcSEcCtD
Dapsone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000166	0.00275	CcSEcCtD
Dapsone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000147	0.00244	CcSEcCtD
Dapsone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00226	CcSEcCtD
Dapsone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.00215	CcSEcCtD
Dapsone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00204	CcSEcCtD
Dapsone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.00204	CcSEcCtD
Dapsone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00197	CcSEcCtD
Dapsone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000119	0.00197	CcSEcCtD
Dapsone—Vomiting—Prednisone—chronic obstructive pulmonary disease	9.59e-05	0.00159	CcSEcCtD
Dapsone—Headache—Prednisone—chronic obstructive pulmonary disease	9.45e-05	0.00156	CcSEcCtD
Dapsone—Nausea—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.00148	CcSEcCtD
Dapsone—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.44e-05	0.000653	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—APIP—chronic obstructive pulmonary disease	5.35e-05	0.000642	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.35e-05	0.000642	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.33e-05	0.00064	CbGpPWpGaD
Dapsone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	5.19e-05	0.000623	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	5.18e-05	0.000622	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GC—chronic obstructive pulmonary disease	5.18e-05	0.000622	CbGpPWpGaD
Dapsone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	5.12e-05	0.000614	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	5.11e-05	0.000614	CbGpPWpGaD
Dapsone—CYP2E1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.08e-05	0.00061	CbGpPWpGaD
Dapsone—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.07e-05	0.000608	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	5.04e-05	0.000605	CbGpPWpGaD
Dapsone—CYP2E1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.01e-05	0.000601	CbGpPWpGaD
Dapsone—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5e-05	0.0006	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.85e-05	0.000582	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.84e-05	0.000581	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.82e-05	0.000578	CbGpPWpGaD
Dapsone—CYP2E1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.82e-05	0.000578	CbGpPWpGaD
Dapsone—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.81e-05	0.000577	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.78e-05	0.000573	CbGpPWpGaD
Dapsone—CYP2E1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.75e-05	0.00057	CbGpPWpGaD
Dapsone—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.74e-05	0.000569	CbGpPWpGaD
Dapsone—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.71e-05	0.000566	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.66e-05	0.00056	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.65e-05	0.000558	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.6e-05	0.000552	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GCLC—chronic obstructive pulmonary disease	4.6e-05	0.000552	CbGpPWpGaD
Dapsone—NAT2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.46e-05	0.000535	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.42e-05	0.000531	CbGpPWpGaD
Dapsone—NAT2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.4e-05	0.000528	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.39e-05	0.000527	CbGpPWpGaD
Dapsone—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.33e-05	0.00052	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.32e-05	0.000519	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	4.26e-05	0.000512	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	4.21e-05	0.000505	CbGpPWpGaD
Dapsone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	4.21e-05	0.000505	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CTGF—chronic obstructive pulmonary disease	4.2e-05	0.000504	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.16e-05	0.0005	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	4.12e-05	0.000494	CbGpPWpGaD
Dapsone—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.11e-05	0.000493	CbGpPWpGaD
Dapsone—NAT2—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.1e-05	0.000492	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	3.99e-05	0.000479	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.94e-05	0.000473	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.92e-05	0.00047	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.89e-05	0.000467	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.88e-05	0.000466	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	3.87e-05	0.000465	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.87e-05	0.000464	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.87e-05	0.000464	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.87e-05	0.000464	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.84e-05	0.00046	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	3.83e-05	0.000459	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.000446	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.7e-05	0.000444	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.7e-05	0.000444	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.66e-05	0.00044	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.66e-05	0.000439	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	3.61e-05	0.000433	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.57e-05	0.000429	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.57e-05	0.000428	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.54e-05	0.000425	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.52e-05	0.000423	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.51e-05	0.000421	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.45e-05	0.000414	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.43e-05	0.000412	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.000409	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.39e-05	0.000407	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	3.35e-05	0.000402	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.34e-05	0.000401	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	3.34e-05	0.000401	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.22e-05	0.000387	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.2e-05	0.000385	CbGpPWpGaD
Dapsone—FMO3—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.18e-05	0.000382	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.11e-05	0.000373	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.07e-05	0.000369	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.03e-05	0.000364	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.99e-05	0.000359	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	2.97e-05	0.000357	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.96e-05	0.000356	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.93e-05	0.000352	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	2.92e-05	0.00035	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.83e-05	0.00034	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.83e-05	0.00034	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000337	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GCLC—chronic obstructive pulmonary disease	2.8e-05	0.000336	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	2.78e-05	0.000333	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.73e-05	0.000327	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.73e-05	0.000327	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.000324	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	2.65e-05	0.000318	CbGpPWpGaD
Dapsone—NAT2—Metabolism—ALB—chronic obstructive pulmonary disease	2.64e-05	0.000317	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.57e-05	0.000308	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.56e-05	0.000308	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.56e-05	0.000307	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000307	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.53e-05	0.000304	CbGpPWpGaD
Dapsone—NAT2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.53e-05	0.000303	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.5e-05	0.0003	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.49e-05	0.000299	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.47e-05	0.000297	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.47e-05	0.000296	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.45e-05	0.000294	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.000287	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.36e-05	0.000283	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.000282	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.32e-05	0.000279	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.32e-05	0.000279	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.32e-05	0.000278	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.24e-05	0.000269	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.23e-05	0.000268	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.22e-05	0.000266	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.2e-05	0.000264	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000264	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.2e-05	0.000264	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	2.16e-05	0.000259	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.13e-05	0.000256	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.000243	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.01e-05	0.000241	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.98e-05	0.000238	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.98e-05	0.000238	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000236	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.96e-05	0.000236	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-05	0.000236	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.94e-05	0.000233	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.94e-05	0.000232	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.93e-05	0.000231	CbGpPWpGaD
Dapsone—FMO3—Metabolism—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000229	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.89e-05	0.000227	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.88e-05	0.000226	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.86e-05	0.000223	CbGpPWpGaD
Dapsone—FMO3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.000219	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.82e-05	0.000219	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.81e-05	0.000217	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.8e-05	0.000217	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000217	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.8e-05	0.000216	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.79e-05	0.000215	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.79e-05	0.000215	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.76e-05	0.000211	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.71e-05	0.000205	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000204	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.68e-05	0.000202	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.67e-05	0.0002	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.65e-05	0.000198	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.63e-05	0.000196	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.6e-05	0.000192	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.000188	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.52e-05	0.000182	CbGpPWpGaD
Dapsone—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.45e-05	0.000175	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000174	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.43e-05	0.000172	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.43e-05	0.000171	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000164	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.36e-05	0.000163	CbGpPWpGaD
Dapsone—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.35e-05	0.000162	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000162	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.35e-05	0.000161	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.34e-05	0.00016	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.000157	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.31e-05	0.000157	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000156	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000154	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.26e-05	0.000152	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.25e-05	0.00015	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000148	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.23e-05	0.000147	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000145	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000144	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.19e-05	0.000143	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.18e-05	0.000141	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	1.17e-05	0.00014	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.16e-05	0.00014	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	0.00014	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.16e-05	0.000139	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000136	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000136	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.13e-05	0.000136	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000133	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.1e-05	0.000132	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.09e-05	0.00013	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.08e-05	0.000129	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000128	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000126	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000125	CbGpPWpGaD
Dapsone—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.01e-05	0.000122	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1e-05	0.000121	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.9e-06	0.000119	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.8e-06	0.000118	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.7e-06	0.000116	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.59e-06	0.000115	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	9.49e-06	0.000114	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	9.48e-06	0.000114	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.45e-06	0.000113	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.43e-06	0.000113	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.32e-06	0.000112	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.3e-06	0.000112	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.23e-06	0.000111	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.84e-06	0.000106	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.75e-06	0.000105	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.74e-06	0.000105	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.69e-06	0.000104	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.67e-06	0.000104	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	8.65e-06	0.000104	CbGpPWpGaD
Dapsone—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	8.45e-06	0.000101	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.24e-06	9.88e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.22e-06	9.86e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.17e-06	9.81e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.06e-06	9.67e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.97e-06	9.57e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	7.73e-06	9.28e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.51e-06	9.01e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	7.49e-06	8.99e-05	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.39e-06	8.87e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.29e-06	8.75e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.19e-06	8.63e-05	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	7.17e-06	8.6e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.12e-06	8.54e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	7.11e-06	8.54e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	6.79e-06	8.15e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.7e-06	8.04e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.65e-06	7.98e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.56e-06	7.87e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.35e-06	7.63e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.33e-06	7.59e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.25e-06	7.51e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.11e-06	7.33e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	5.95e-06	7.14e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.79e-06	6.95e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.71e-06	6.85e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.69e-06	6.83e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	5.6e-06	6.72e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.59e-06	6.7e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.35e-06	6.43e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.34e-06	6.41e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.26e-06	6.31e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	4.84e-06	5.81e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	4.63e-06	5.55e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	4.49e-06	5.39e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	4.4e-06	5.29e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.39e-06	5.26e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.33e-06	5.19e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	4.32e-06	5.18e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	4.13e-06	4.96e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.03e-06	4.84e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.94e-06	4.73e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.82e-06	4.59e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.77e-06	4.52e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	3.38e-06	4.06e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.6e-06	3.12e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-06	2.98e-05	CbGpPWpGaD
